bone-targeted therapy for prostate cancer: radium-223
Published 6 years ago • 1.3K plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
4:27
radium-223 as bone-targeted therapy for crpc
-
4:10
optimal time for prostate cancer bone-targeted therapy
-
4:55
bone targeted therapy for metastatic prostate cancer
-
14:14
bone targeted agents in metastatic prostate cancer: denosumab, bisphosphonates and radium-223
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
3:27
bone supportive therapy and radium-223 for metastatic prostate cancer
-
6:10
key updates: bone-targeted therapy for metastatic crpc
-
15:05
radium-223 in bone-metastatic castration-resistant prostate cancer
-
13:09
radium-223 alone and with other agents for prostate cancer
-
22:16
bone-targeted therapy for prostate cancer
-
7:01
safety and efficacy of bone-targeted therapy for mcrpc
-
9:54
radium-223 for treatment of prostate cancer
-
5:07
optimizing therapy with radium-223 for prostate cancer
-
10:33
ep. 12: what is radium 223’s role in mcrpc management?
-
1:27
dr. morris on bone biomarkers for radium-223 in prostate cancer
-
9:48
radium-223 in combination therapy for mcrpc
-
3:47
bone-migrated prostate cancer and radium-223 therapy
-
2:14
radium-223 and metastatic prostate cancer
-
3:14
radium-223 for mcrpc: a radiation oncologist’s viewpoint